Etrych T - Search Results

1

Glycopolymers Decorated with 3-O-Substituted Thiodigalactosides as Potent Multivalent Inhibitors of Galectin-3.

Vrbata D, Filipová M, Tavares MR, Červený J, Vlachová M, Šírová M, Pelantová H, Petrásková L, Bumba L, Konefał R, Etrych T, Křen V, Chytil P, Bojarová P. Vrbata D, et al. Among authors: etrych t. J Med Chem. 2022 Mar 10;65(5):3866-3878. doi: 10.1021/acs.jmedchem.1c01625. Epub 2022 Feb 14. J Med Chem. 2022. PMID: 35157467

2

HPMA copolymers with pH-controlled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activity.

Ulbrich K, Etrych T, Chytil P, Jelínková M, Ríhová B. Ulbrich K, et al. Among authors: etrych t. J Control Release. 2003 Feb 21;87(1-3):33-47. doi: 10.1016/s0168-3659(02)00348-6. J Control Release. 2003. PMID: 12618021

3

Drug-HPMA-HuIg conjugates effective against human solid cancer.

Ríhová B, Strohalm J, Kubácková K, Jelínková M, Rozprimová L, Sírová M, Plocová D, Mrkvan T, Kovár M, Pokorná J, Etrych T, Ulbrich K. Ríhová B, et al. Among authors: etrych t. Adv Exp Med Biol. 2003;519:125-43. doi: 10.1007/0-306-47932-x_8. Adv Exp Med Biol. 2003. PMID: 12675212 Review. No abstract available.

4

Cytostatic and immunomobilizing activities of polymer-bound drugs: experimental and first clinical data.

Ríhová B, Strohalm J, Prausová J, Kubácková K, Jelínková M, Rozprimová L, Sírová M, Plocová D, Etrych T, Subr V, Mrkvan T, Kovár M, Ulbrich K. Ríhová B, et al. Among authors: etrych t. J Control Release. 2003 Aug 28;91(1-2):1-16. doi: 10.1016/s0168-3659(03)00235-9. J Control Release. 2003. PMID: 12932633

5

Polymeric anticancer drugs with pH-controlled activation.

Ulbrich K, Etrych T, Chytil P, Pechar M, Jelinkova M, Rihova B. Ulbrich K, et al. Among authors: etrych t. Int J Pharm. 2004 Jun 11;277(1-2):63-72. doi: 10.1016/j.ijpharm.2003.02.001. Int J Pharm. 2004. PMID: 15158969

6

Antibody-targeted polymer-doxorubicin conjugates with pH-controlled activation.

Ulbrich K, Etrych T, Chytil P, Jelínková M, Ríhová B. Ulbrich K, et al. Among authors: etrych t. J Drug Target. 2004;12(8):477-89. doi: 10.1080/10611860400011869. J Drug Target. 2004. PMID: 15621674

7

Chemotherapy based on HPMA copolymer conjugates with pH-controlled release of doxorubicin triggers anti-tumor immunity.

Mrkvan T, Sirova M, Etrych T, Chytil P, Strohalm J, Plocova D, Ulbrich K, Rihova B. Mrkvan T, et al. Among authors: etrych t. J Control Release. 2005 Dec 10;110(1):119-29. doi: 10.1016/j.jconrel.2005.09.028. Epub 2005 Nov 2. J Control Release. 2005. PMID: 16269198

8

Properties of HPMA copolymer-doxorubicin conjugates with pH-controlled activation: effect of polymer chain modification.

Chytil P, Etrych T, Konák C, Sírová M, Mrkvan T, Ríhová B, Ulbrich K. Chytil P, et al. Among authors: etrych t. J Control Release. 2006 Sep 28;115(1):26-36. doi: 10.1016/j.jconrel.2006.06.028. Epub 2006 Jun 30. J Control Release. 2006. PMID: 16899320

9

New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting.

Chytil P, Etrych T, Konák C, Sírová M, Mrkvan T, Boucek J, Ríhová B, Ulbrich K. Chytil P, et al. Among authors: etrych t. J Control Release. 2008 Apr 21;127(2):121-30. doi: 10.1016/j.jconrel.2008.01.007. Epub 2008 Jan 30. J Control Release. 2008. PMID: 18304673

10

Conjugates of doxorubicin with graft HPMA copolymers for passive tumor targeting.

Etrych T, Chytil P, Mrkvan T, Sírová M, Ríhová B, Ulbrich K. Etrych T, et al. J Control Release. 2008 Dec 18;132(3):184-92. doi: 10.1016/j.jconrel.2008.04.017. Epub 2008 Apr 29. J Control Release. 2008. PMID: 18534705

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters